{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:26:41Z","timestamp":1790494001948,"version":"4.1.0"},"reference-count":34,"publisher":"American Chemical Society (ACS)","issue":"13","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":122,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_13065"],"award-info":[{"award-number":["MC_PC_13065"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001306","name":"Health Protection Agency","doi-asserted-by":"publisher","award":["109502"],"award-info":[{"award-number":["109502"]}],"id":[{"id":"10.13039\/501100001306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001306","name":"Health Protection Agency","doi-asserted-by":"publisher","award":["109506"],"award-info":[{"award-number":["109506"]}],"id":[{"id":"10.13039\/501100001306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>It is urgent to find new antibiotic classes with activity against multidrug-resistant (MDR) Gram-negative pathogens as the pipeline of antibiotics is essentially empty. Modified pyrrolobenzodiazepines with a C8-linked aliphatic heterocycle provide a new class of broad-spectrum antibacterial agents with activity against MDR Gram-negative bacteria, including WHO priority pathogens. The structure\u2013activity relationship established that the third ring was particularly important for Gram-negative activity. Minimum inhibitory concentrations for the lead compounds ranged from 0.125 to 2 mg\/L for MDR Gram-negative, excluding Pseudomonas aeruginosa, and between 0.03 and 1 mg\/L for MDR Gram-positive species. The lead compounds were rapidly bactericidal with &amp;gt;5 log reduction in viable count within 4 h for Acinetobacter baumannii and Klebsiella pneumoniae. The lead compound inhibited DNA gyrase in gel-based assays, with an IC50 of 3.16 \u00b1 1.36 mg\/L. This study provides a new chemical scaffold for developing novel broad-spectrum antibiotics which can help replenish the pipeline of antibiotics.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.0c00328","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T12:57:57Z","timestamp":1591707477000},"page":"6941-6958","source":"Crossref","is-referenced-by-count":25,"title":["New Broad-Spectrum\nAntibiotics Containing a Pyrrolobenzodiazepine\nRing with Activity against Multidrug-Resistant Gram-Negative Bacteria"],"prefix":"10.1021","volume":"63","author":[{"given":"Pietro","family":"Picconi","sequence":"first","affiliation":[{"name":"King\u2019s College London , , ,","place":["London, U.K., SE1 9NH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte K.","family":"Hind","sequence":"additional","affiliation":[{"name":"Public Health England , , Porton Down , , ,","place":["Salisbury, Wiltshire, U.K., SP4 0JG"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazi S.","family":"Nahar","sequence":"additional","affiliation":[{"name":"King\u2019s College London , , ,","place":["London, U.K., SE1 9NH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Jamshidi","sequence":"additional","affiliation":[{"name":"King\u2019s College London , , ,","place":["London, U.K., SE1 9NH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Di Maggio","sequence":"additional","affiliation":[{"name":"King\u2019s College London , , ,","place":["London, U.K., SE1 9NH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naima","family":"Saeed","sequence":"additional","affiliation":[{"name":"King\u2019s College London , , ,","place":["London, U.K., SE1 9NH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Evans","sequence":"additional","affiliation":[{"name":"Public Health England , , Porton Down , , ,","place":["Salisbury, Wiltshire, U.K., SP4 0JG"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Solomons","sequence":"additional","affiliation":[{"name":"Public Health England , , Porton Down , , ,","place":["Salisbury, Wiltshire, U.K., SP4 0JG"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Wand","sequence":"additional","affiliation":[{"name":"Public Health England , , Porton Down , , ,","place":["Salisbury, Wiltshire, U.K., SP4 0JG"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Mark","family":"Sutton","sequence":"additional","affiliation":[{"name":"Public Health England , , Porton Down , , ,","place":["Salisbury, Wiltshire, U.K., SP4 0JG"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8566-8648","authenticated-orcid":true,"given":"Khondaker Miraz","family":"Rahman","sequence":"additional","affiliation":[{"name":"King\u2019s College London , , ,","place":["London, U.K., SE1 9NH"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"2026090218250301500_cit1","unstructured":"World Health Organization.\n          .  Global Antimicrobial Resistance Surveillance\nSystem (GLASS) Report: Early Implementation 2017\u20132018, 2018."},{"key":"2026090218250301500_cit2","volume-title":"Antimicrobial Resistance: Tackling a Crisis\nfor the Health and Wealth of Nations","author":"Review on Antimicrobial Resistance.","year":"2014"},{"key":"2026090218250301500_cit3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","article-title":"Drug combinations: a strategy to\nextend the life of\nantibiotics in the 21st century","volume":"17","author":"Tyers","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"2026090218250301500_cit4","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1021\/cr100120f","article-title":"Synthesis of DNA-interactive\npyrrolo[2,1-c][1,4]benzodiazepines\n(PBDs)","volume":"111","author":"Antonow","year":"2011","journal-title":"Chem. Rev."},{"key":"2026090218250301500_cit5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/med.20212","article-title":"Biosynthesis,\nsynthesis, and biological activities of pyrrolobenzodiazepines","volume":"32","author":"Gerratana","year":"2012","journal-title":"Med. Res. Rev."},{"key":"2026090218250301500_cit6","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.1021\/ja00952a050","article-title":"Isolation\nand characterization of anthramycin a new antitumor antibiotic","volume":"87","author":"Leimgruber","year":"1965","journal-title":"J. Am. Chem. Soc."},{"key":"2026090218250301500_cit7","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1021\/jm301882a","article-title":"GC-targeted\nC8-linked pyrrolobenzodiazepine\u2013biaryl conjugates with femtomolar\nin vitro cytotoxicity and in vivo antitumor activity in mouse models","volume":"56","author":"Rahman","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026090218250301500_cit8","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1021\/acs.jmedchem.8b01849","article-title":"Effects of systematic\nshortening of noncovalent C8 side chain on the cytotoxicity and NF-\u03baB\ninhibitory capacity of pyrrolobenzodiazepines (PBDs)","volume":"62","author":"Corcoran","year":"2019","journal-title":"J. Med. Chem."},{"key":"2026090218250301500_cit9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1021\/ml100131b","article-title":"DNA sequence preference\nand adduct orientation of pyrrolo 2,1-c 1,4 benzodiazepine antitumor\nagents","volume":"1","author":"Rahman","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"2026090218250301500_cit10","doi-asserted-by":"publisher","first-page":"13756","DOI":"10.1021\/ja902986x","article-title":"The pyrrolobenzodiazepine dimer SJG-136 forms sequence-dependent\nintrastrand DNA cross-links and monoalkylated adducts in addition\nto interstrand cross-Links","volume":"131","author":"Rahman","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"2026090218250301500_cit11","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1021\/jm020124h","article-title":"Design,\nsynthesis, and evaluation of new noncross-linking pyrrolobenzodiazepine\ndimers with efficient DNA binding ability and potent antitumor activity","volume":"45","author":"Kamal","year":"2002","journal-title":"J. Med. Chem."},{"key":"2026090218250301500_cit12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/anie.201510610","article-title":"From anthramycin\nto pyrrolobenzodiazepine (PBD)-containing antibody\u2013drug conjugates\n(ADCs)","volume":"56","author":"Mantaj","year":"2017","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026090218250301500_cit13","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1021\/acsmedchemlett.6b00062","article-title":"Design\nand synthesis of tesirine, a clinical antibody-drug conjugate pyrrolobenzodiazepine\ndimer payload","volume":"7","author":"Tiberghien","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"2026090218250301500_cit14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1021\/acsinfecdis.7b00130","article-title":"C8-linked\npyrrolobenzodiazepine monomers with inverted building blocks show\nselective activity against multidrug resistant Gram-positive bacteria","volume":"4","author":"Andriollo","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"2026090218250301500_cit15","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1093\/jac\/dks127","article-title":"Antistaphylococcal\nactivity of DNA-interactive pyrrolobenzodiazepine\n(PBD) dimers and PBD-biaryl conjugates","volume":"67","author":"Rahman","year":"2012","journal-title":"J. Antimicrob.\nChemother."},{"key":"2026090218250301500_cit16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/jac\/dkr044","article-title":"The minor groove-binding\nagent ELB-21 forms multiple\ninterstrand and intrastrand covalent cross-links with duplex DNA and\ndisplays potent bactericidal activity against methicillin-resistant\nStaphylococcus aureus","volume":"66","author":"Rosado","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"2026090218250301500_cit17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/nyas.13598","article-title":"The challenge of converting Gram-positive-only compounds\ninto broad-spectrum antibiotics","volume":"1435","author":"Richter","year":"2019","journal-title":"Ann. N. Y.\nAcad. Sci."},{"key":"2026090218250301500_cit18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060666","article-title":"The efflux inhibitor phenylalanine-arginine\nbeta-naphthylamide (PA\u03b2N) permeabilizes the outer membrane of\ngram-negative bacteria","volume":"8","author":"Lamers","year":"2013","journal-title":"PLoS One"},{"key":"2026090218250301500_cit19","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.1021\/jm051199z","article-title":"Design, synthesis,\nand biophysical and biological evaluation of a series of pyrrolobenzodiazepine\u2013poly(N-methylpyrrole)\nconjugates","volume":"49","author":"Wells","year":"2006","journal-title":"J. Med. Chem."},{"key":"2026090218250301500_cit20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nmeth895","article-title":"A comprehensive library of fluorescent\ntranscriptional reporters for Escherichia coli","volume":"3","author":"Zaslaver","year":"2006","journal-title":"Nat. Methods"},{"key":"2026090218250301500_cit21","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1128\/aac.03475-14","article-title":"A novel\nhigh-throughput cell-based\nassay aimed at identifying inhibitors of DNA metabolism in bacteria","volume":"58","author":"Fan","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026090218250301500_cit22","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1021\/jm981124d","article-title":"Design, synthesis,\nand evaluation of a novel sequence-selective epoxide-containing DNA\ncross-linking agent based on the pyrrolo [2, 1-c][1, 4] benzodiazepine\nsystem","volume":"42","author":"Wilson","year":"1999","journal-title":"J. Med. Chem."},{"key":"2026090218250301500_cit23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1365-2958.1988.tb00050.x","article-title":"Cloning and characterization of an\nalbicidin resistance gene from Klebsiella oxytoca","volume":"2","author":"Walker","year":"1988","journal-title":"Mol. Microbiol."},{"key":"2026090218250301500_cit24","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/s1473-3099(18)30513-9","article-title":"Analysis of the clinical\nantibacterial and antituberculosis pipeline","volume":"19","author":"Theuretzbacher","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"2026090218250301500_cit25","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1128\/jb.01479-12","article-title":"Sequence-verified two-allele transposon\nmutant library\nfor Pseudomonas aeruginosa PAO1","volume":"194","author":"Held","year":"2012","journal-title":"J. Bacteriol."},{"key":"2026090218250301500_cit26","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00352-17","article-title":"Comprehensive arrayed\ntransposon mutant library of Klebsiella pneumoniae outbreak strain\nKPNIH1","volume":"199","author":"Ramage","year":"2017","journal-title":"J. Bacteriol."},{"key":"2026090218250301500_cit27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to\ndetermine the minimal inhibitory concentration (MIC) of antimicrobial\nsubstances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat. Protoc."},{"key":"2026090218250301500_cit28","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1128\/aac.00141-06","article-title":"Efflux pump overexpression in multiple-antibiotic-resistant\nmutants of Bacteroides fragilis","volume":"50","author":"Pumbwe","year":"2006","journal-title":"Antimicrob.\nAgents Chemother."},{"key":"2026090218250301500_cit29","doi-asserted-by":"publisher","first-page":"14339","DOI":"10.1073\/pnas.2036282100","article-title":"Comprehensive\ntransposon\nmutant library of Pseudomonas aeruginosa","volume":"100","author":"Jacobs","year":"2003","journal-title":"Proc.\nNatl. Acad. Sci. U.S.A."},{"key":"2026090218250301500_cit30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl504","article-title":"High-throughput assays for DNA gyrase\nand other topoisomerases","volume":"34","author":"Maxwell","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"2026090218250301500_cit31","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1021\/acs.jmedchem.7b00108","article-title":"Triaryl benzimidazoles\nas a new class of antibacterial agents against resistant pathogenic\nmicroorganisms","volume":"60","author":"Picconi","year":"2017","journal-title":"J. Med. Chem."},{"key":"2026090218250301500_cit32","doi-asserted-by":"publisher","first-page":"W537","DOI":"10.1093\/nar\/gky379","article-title":"The Galaxy\nplatform for accessible, reproducible and\ncollaborative biomedical analyses: 2018 update","volume":"46","author":"Afgan","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2026090218250301500_cit33","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/jcc.23205","article-title":"Cluster-based molecular\ndocking study for in silico identification of novel 6-fluoroquinolones\nas potential inhibitors against Mycobacterium tuberculosis","volume":"34","author":"Minovski","year":"2013","journal-title":"J. Comput. Chem."},{"key":"2026090218250301500_cit34","doi-asserted-by":"publisher","first-page":"935","DOI":"10.4155\/fmc-2018-0472","article-title":"Cyclohexyl\namide-based novel bacterial\ntopoisomerase inhibitors with prospective GyrA-binding fragments","volume":"11","author":"Kolaric\u030c","year":"2019","journal-title":"Future Med. Chem."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.0c00328","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/63\/13\/6941\/67036056\/acs.jmedchem.0c00328.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/63\/13\/6941\/67036056\/acs.jmedchem.0c00328.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:25:10Z","timestamp":1788387910000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/63\/13\/6941\/1305915\/New-Broad-Spectrum-Antibiotics-Containing-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":34,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2020,6,9]]},"published-print":{"date-parts":[[2020,7,9]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00328","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]}}}